Opinion

Video

Managing Cognitive and Sexual Health in Prostate Cancer Patients on Hormonal Therapy

Key Takeaways

  • Early and aggressive treatment strategies are crucial for improving outcomes in high-risk metastatic castration-sensitive prostate cancer.
  • Combining androgen deprivation therapy with novel hormonal agents or chemotherapy enhances survival rates.
SHOW MORE

Panelists discuss how managing cognitive and sexual health in prostate cancer patients undergoing hormonal therapy is crucial, emphasizing the need for proactive communication and tailored interventions to enhance overall quality of life.

Video content above is prompted by the following:

  1. Finally, to close out, which clinical pearls would you like to share with other health care providers who treat patients with high-risk metastatic castration-sensitive prostate cancer?
Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.